Paying users zone. Data is covered by hidden.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal
Verified by Visa MasterCard SecureCode American Express SafeKey
Next
Microsoft Excel LibreOffice Calc

Merck & Co. Inc. (MRK)

Liquidity Analysis

Difficulty: Beginner

Liquidity ratios measure the company’s ability to meet its short-term obligations.

Ratios (Summary)

Merck & Co. Inc., liquidity ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Current ratio hidden hidden hidden hidden hidden
Quick ratio hidden hidden hidden hidden hidden
Cash ratio hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-27).

Ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Merck & Co. Inc.’s current ratio deteriorated from 2016 to 2017 and from 2017 to 2018.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Merck & Co. Inc.’s quick ratio deteriorated from 2016 to 2017 and from 2017 to 2018.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Merck & Co. Inc.’s cash ratio deteriorated from 2016 to 2017 and from 2017 to 2018.

Current Ratio

Merck & Co. Inc., current ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (USD $ in millions)
Current assets hidden hidden hidden hidden hidden
Current liabilities hidden hidden hidden hidden hidden
Ratio
Current ratio1 hidden hidden hidden hidden hidden
Benchmarks
Current Ratio, Competitors
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Current Ratio, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Current Ratio, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-27).

2018 Calculations

1 Current ratio = Current assets ÷ Current liabilities
= hidden ÷ hidden = hidden

Ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Merck & Co. Inc.’s current ratio deteriorated from 2016 to 2017 and from 2017 to 2018.

Quick Ratio

Merck & Co. Inc., quick ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (USD $ in millions)
Cash and cash equivalents hidden hidden hidden hidden hidden
Short-term investments hidden hidden hidden hidden hidden
Accounts receivable, net of allowance for doubtful accounts hidden hidden hidden hidden hidden
Total quick assets hidden hidden hidden hidden hidden
Current liabilities hidden hidden hidden hidden hidden
Ratio
Quick ratio1 hidden hidden hidden hidden hidden
Benchmarks
Quick Ratio, Competitors
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Quick Ratio, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Quick Ratio, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-27).

2018 Calculations

1 Quick ratio = Total quick assets ÷ Current liabilities
= hidden ÷ hidden = hidden

Ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Merck & Co. Inc.’s quick ratio deteriorated from 2016 to 2017 and from 2017 to 2018.

Cash Ratio

Merck & Co. Inc., cash ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (USD $ in millions)
Cash and cash equivalents hidden hidden hidden hidden hidden
Short-term investments hidden hidden hidden hidden hidden
Total cash assets hidden hidden hidden hidden hidden
Current liabilities hidden hidden hidden hidden hidden
Ratio
Cash ratio1 hidden hidden hidden hidden hidden
Benchmarks
Cash Ratio, Competitors
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Cash Ratio, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Cash Ratio, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-27).

2018 Calculations

1 Cash ratio = Total cash assets ÷ Current liabilities
= hidden ÷ hidden = hidden

Ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Merck & Co. Inc.’s cash ratio deteriorated from 2016 to 2017 and from 2017 to 2018.